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RATIONALE: Intranasal administration is one of the main routes of allergen challenge in mouse models of 
airway disease. Although it is widely used, it is not well established the amount of allergen that reaches the 
lung or is lost to the gastrointestinal tract. The local distribution of the challenge solution within the airways is 
also unknown. The aim of this study was to assess the distribution immediately after intranasal delivery using 
a Positron Emission Tomography scanner (PET). 
 
METHODS: Fifteen BALB/c mice, 15-20 weeks-old, were studied. Thirty microliters containing 300mCi of 
2-deoxy-2-[18F] fluoro-D-glucose (FDG) were administered intranasally. Mice were anesthetized and imaged 
during 30 min in a dedicated small-animal PET scanner (rPET, SUINSA). 
Images were reconstructed by the 3D-Filtered Back Projection (3D-FBP) method and Regions of Interest 
(ROIs) were drawn on coronal and axial sections to obtain quantitative data of lung activity. Dynamic curves 
were obtained at 40 sec/frame and the value at initial time was extrapolated after exponential fitting. 
 
RESULTS: Of the total dose administered, 31.2%68.5% (mean6SD) reached the lower airways. A 
comparable percentage was delivered to each lung with a 51612% estimate located into the right lung. The 
tracer distribution was homogeneous within the areas reached, as previously assessed visually. 
 
CONCLUSION: PET imaging confirms that intranasal route is a suitable technique for delivering allergenic 
fluids into the lower airways. However, it should be taken into account that, in average, only one third of the 
administered dose reaches the anatomical target. 
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